Drawing for IOVANCE BIOTHERAPEUTICS

USPTO serial 90398613

IOVANCE BIOTHERAPEUTICS

Reviewed by CopyMark Law Group

Reg. 7922016Status 700Registered
Filing date
Status date
Registration date
Aug 26, 2025
Examiner
LEE, YATSYE ISADORA
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with IOVANCE BIOTHERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Carla B. Oakley

Carla B. Oakley MORGAN, LEWIS & BOCKIUS LLP600 Montgomery Street, Suite 2300SAN FRANCISCO, CA 94111United States

Goods and services

ClassDescriptionStatusFirst use
038telecommunications services, namely, transmission of data and graphics between healthcare providers via global and local computer networks in the fields of telehealth and telemedicineACTIVEFeb 16, 2024
042providing temporary use of non-downloadable computer software for scheduling and tracking medical patient appointments, medical laboratory services, medical procedures, and for use in providing data analytics in the fields of medical research, cancer treatments and drug and immunotherapy development; software as a service (SaaS) services featuring software for tracking and monitoring chain of custody and chain of identity of cell therapies; providing medical and scientific research information in the field of drug development and medical treatment development for delivering streamlined treatment information and improving communication among stakeholders in providing medical treatment; providing medical and scientific research information in the fields of medical research and cancer treatments; software as a service (SAAS) services featuring software for collecting, organizing, obtaining, and managing patient information, facilitating and handling communications between patients and providers, and providing advice and referrals in the fields of medicine, medical care, and healthcare; platform as a service (PAAS) featuring computer software platforms for online collecting, organizing, obtaining, and managing patient information, facilitating and handling communications between patients and providers; software as a service (SAAS) services featuring software for managing the supply of tumor shippers, temperature monitors and GPS trackers provided to sites involved in the provision of immunotherapy treatments and cancer treatmentsACTIVEJun 30, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 7, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 7, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 7, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 26, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 26, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 4, 2025SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Aug 4, 2025CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jun 16, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 16, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 16, 2025ALIEASSIGNED TO LIE—
Jun 10, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 10, 2025XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Mar 10, 2025XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Dec 10, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 10, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 10, 2024CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 19, 2024SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Nov 19, 2024AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 16, 2024IUAFUSE AMENDMENT FILED—
Sep 16, 2024EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Mar 14, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 13, 2024EX5GSOU EXTENSION 5 GRANTED—
Mar 13, 2024EXT5SOU EXTENSION 5 FILED—
Mar 13, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 16, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 14, 2023EX4GSOU EXTENSION 4 GRANTED—
Aug 14, 2023EXT4SOU EXTENSION 4 FILED—
Aug 14, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 21, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 17, 2023EX3GSOU EXTENSION 3 GRANTED—
Feb 17, 2023EXT3SOU EXTENSION 3 FILED—
Feb 17, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 3, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 1, 2022EX2GSOU EXTENSION 2 GRANTED—
Sep 1, 2022EXT2SOU EXTENSION 2 FILED—
Sep 1, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 23, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 23, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 23, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 23, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 23, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 29, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 27, 2022EX1GSOU EXTENSION 1 GRANTED—
Jan 27, 2022EXT1SOU EXTENSION 1 FILED—
Jan 27, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 14, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 20, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 20, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 30, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 16, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 16, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Jun 16, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 16, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 16, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 16, 2021DOCKASSIGNED TO EXAMINER—
Mar 5, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 24, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance